BURDEN OF DISEASE ANALYSIS OF PSORIATIC ARTHRITIS IN HUNGARY
Author(s)
Hegyi R1, Nagy B1, Koncz A2, Huybrechts I3, Lavicky J4, Ferenczik A1
1Healthware Consulting Ltd., Budapest, Hungary, 2UCB Pharma, Budapest, Hungary, 3UCB Pharma, Brussels, Belgium, 4UCB Pharma, Prague, Czech Republic
OBJECTIVES Psoriatic arthritis (PsA) entails an individual burden to patients and ties up resources. This study aimed to assess the total costs of PsA, including the indirect burden of PsA patients in Hungary and to obtain an overview of patients’ status, demographics, morbidity, and working capacity. METHODS Between January–March 2014, a questionnaire survey was conducted among PsA patients and filled out voluntarily and anonymously. Missing data was not imputed in the analysis; considered patient number is presented next to results if lower than total patient number. RESULTS
Conference/Value in Health Info
2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands
Value in Health, Vol. 17, No. 7 (November 2014)
Code
PMS25
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Musculoskeletal Disorders